ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 70 filers reported holding ODONATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | -82.3% | 9,149 | +0.3% | 0.00% | -100.0% |
| Q4 2020 | $175,000 | +66.7% | 9,124 | +16.7% | 0.00% | 0.0% |
| Q3 2020 | $105,000 | -69.0% | 7,819 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $339,000 | +115.9% | 7,997 | +40.5% | 0.00% | +100.0% |
| Q1 2020 | $157,000 | -34.0% | 5,692 | -22.5% | 0.00% | 0.0% |
| Q4 2019 | $238,000 | +23.3% | 7,343 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $193,000 | +6.6% | 7,404 | +50.1% | 0.00% | 0.0% |
| Q2 2019 | $181,000 | +88.5% | 4,932 | +14.0% | 0.00% | – |
| Q1 2019 | $96,000 | +52.4% | 4,325 | -3.1% | 0.00% | – |
| Q4 2018 | $63,000 | -27.6% | 4,465 | -0.8% | 0.00% | – |
| Q3 2018 | $87,000 | -11.2% | 4,500 | +1.8% | 0.00% | – |
| Q2 2018 | $98,000 | +6.5% | 4,419 | +2.3% | 0.00% | – |
| Q1 2018 | $92,000 | – | 4,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $53,060,000 | 14.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $1,710,000 | 0.93% |
| Boxer Capital, LLC | 5,607,086 | $19,176,000 | 0.65% |
| Samsara BioCapital, LLC | 700,421 | $2,395,000 | 0.44% |
| SABBY MANAGEMENT, LLC | 634,728 | $2,171,000 | 0.42% |
| Prosight Management, LP | 117,621 | $402,000 | 0.33% |
| QCM Cayman, Ltd. | 15,478 | $53,000 | 0.16% |
| Ikarian Capital, LLC | 1,336,412 | $4,571,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 169,198 | $579,000 | 0.13% |
| Walleye Capital LLC | 273,000 | $934,000 | 0.05% |